Citation Impact
Citing Papers
HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol
2005 Standout
The safety of vedolizumab for ulcerative colitis and Crohn's disease
2016
KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)
2009 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Drug-induced hepatic steatosis in absence of severe mitochondrial dysfunction in HepaRG cells: proof of multiple mechanism-based toxicity
2020
Effect of Intravenous Albumin on Renal Impairment and Mortality in Patients with Cirrhosis and Spontaneous Bacterial Peritonitis
1999
Drug-induced toxic epidermal necrolysis (Lyell syndrome) in patients infected with the human immunodeficiency virus
1992
P450 Enzymes
1992
Herbal Products and the Liver: A Review of Adverse Effects and Mechanisms
2014
Structural Alerts, Reactive Metabolites, and Protein Covalent Binding: How Reliable Are These Attributes as Predictors of Drug Toxicity?
2009
Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies
2005 Standout
A Model to Predict Survival in Patients With End–Stage Liver Disease
2001 Standout
Small-Vessel Vasculitis
1997 Standout
Infections in Patients With Cirrhosis Increase Mortality Four-Fold and Should Be Used in Determining Prognosis
2010
Causality assessment of adverse reactions to drugs—II. An original model for validation of drug causality assessment methods: Case reports with positive rechallenge
1993
Harmless Herbs? A Review of the Recent Literature
1998 Standout
Burden of liver diseases in the world
2018 Standout
Herb-drug interactions
2000 Standout
Atopic dermatitis
2015 Standout
The Risk–Benefit Profile of Commonly Used Herbal Therapies: Ginkgo, St. John's Wort, Ginseng, Echinacea, Saw Palmetto, and Kava
2002 Standout
Amoxicillin-clavulanic acid versus cefotaxime in the therapy of bacterial infections in cirrhotic patients
2000
Health-promoting properties of common herbs
1999
Rare diseases bullet 5: Primary pulmonary hypertension
1999
The liver and lovastatin
2002
Drug-Induced Hepatotoxicity
2003 Standout
Hepatotoxicity of germander in mice
1994
Safety of zoledronic acid and incidence of osteonecrosis of the jaw (ONJ) during adjuvant therapy in a randomised phase III trial (AZURE: BIG 01–04) for women with stage II/III breast cancer
2011
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Case Report: Ticlopidine-Induced Cholestatic Hepatitis Report of Three Cases and Review of the Literature
1998
Hepatotoxicity of herbal remedies.
1989
Herbal hepatotoxicity: An expanding but poorly defined problem
2000
Acute hepatitis induced by greater celandine (Chelidonium majus)
1999
Analysis of Missed Cases of Abusive Head Trauma
1999 Standout
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Acute Pancreatitis
2016 Standout
Spontaneous Bacterial Peritonitis: An Update
1995
Antibody therapy of cancer
2012 Standout
Etoposide (VP 16-213) induced hepatitis. Report of three cases following standard-dose treatments
1991
Allergic Rhinitis and Its Impact on Asthma
2001 Standout
Herbal Hepatotoxicity
2007
Portal hypertensive bleeding in cirrhosis
2016 Standout
Lead Poisoning Associated with the Use of Ayurvedic Metal-Mineral Tonics
1996
The biochemistry and medical significance of the flavonoids
2002 Standout
Coumarins: Old Compounds with Novel Promising Therapeutic Perspectives
2010 Standout
Toxicity of Complementary Therapies: An Eastern Perspective
2000
Drug-Induced Severe Skin Reactions
1995
Efficacy and safety of systemic treatments for moderate-to-severe atopic dermatitis: A systematic review
2013
Increased expression of cytochrome P450 2E1 in nonalcoholic fatty liver disease: Mechanisms and pathophysiological role
2011
Safety Issues with Herbal Medicine
2000
Medication Use and the Risk of Stevens–Johnson Syndrome or Toxic Epidermal Necrolysis
1995 Standout
Anti-liver endoplasmic reticulum autoantibodies are directed against human cytochrome P-450IA2. A specific marker of dihydralazine-induced hepatitis.
1990
Cough and Angioneurotic Edema Associated with Angiotensin-Converting Enzyme Inhibitor Therapy
1992
Liver injuries induced by herbal medicine, Syo-saiko-to (xiao-chai-hu-tang)
1995
Toxicological Problems Resulting from Exposure to Traditional Remedies and Food Supplements
1994
Mechanisms of halothane toxicity: Novel insights
1993
Traditional Chinese medicine
2008 Standout
Traditional Chinese herbal medicine
1995
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
Ulcerative colitis
2016 Standout
Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases
1999 Standout
Severe Adverse Cutaneous Reactions to Drugs
1994 Standout
An economic analysis of norfloxacin prophylaxis against spontaneous bacterial peritonitis
1997
Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of Cirrhosis
2013 Standout
Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)
1997 Standout
Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document
2000 Standout
Systemic Antibiotic Prophylaxis After Gastrointestinal Hemorrhage in Cirrhotic Patients With A High Risk of Infection
1996
Toxic epidermal necrolysis after bone marrow transplantation: Study of nine cases
1990
REGISTRATION OF INTERSTITIAL LUNG DISEASES BY 20 CENTRES OF RESPIRATORY MEDICINE IN FLANDERS
2001
Continuous Versus Inpatient Prophylaxis of the First Episode of Spontaneous Bacterial Peritonitis With Norfloxacin
1997
TGFβ Signaling in Growth Control, Cancer, and Heritable Disorders
2000 Standout
Herbal Medicines and Perioperative Care
2001 Standout
Herbal bioactivation: The good, the bad and the ugly
2003
Drug-Induced Pancreatitis
2012
Complementary and alternative medicine in chronic liver disease
2001
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
A marker for Stevens–Johnson syndrome
2004 StandoutNature
Gastrointestinal toxicities of novel agents in cancer therapy
2009
A prospective study of bacterial infections in patients with cirrhosis
1993
Herbs as Medicines
1998
Bisphosphonates and Bone Fractures in Long-term Kidney Transplant Recipients
2008
Autoantibodies against Cytochromes P‐450 in Drug‐Induced Autoimmune Hepatitis
1993
Analysis of clinical course and prognosis of culture-positive spontaneous bacterial peritonitis and neutrocytic ascites
1992
Osteonecrosis of the jaw complicating bisphosphonate treatment for bone disease in multiple myeloma: an overview with recommendations for prevention and treatment
2008
Biological effects of essential oils – A review
2007 Standout
Survival after a first episode of spontaneous bacterial peritonitis. Prognosis of potential candidates for orthotopic liver transplantation
1995
Incidence and Prevalence of Idiopathic Pulmonary Fibrosis
2006 Standout
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Hepatitis induced by traditional Chinese herbs; possible toxic components.
1995
Oral ciprofloxacin after a short course of intravenous ciprofloxacin in the treatment of spontaneous bacterial peritonitis: results of a multicenter, randomized study
2000
Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design
2018 Standout
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (April 2020)
2020 Standout
Toxic epidermal necrolysis (Lyell syndrome). Incidence and drug etiology in France, 1981-1985
1990
The ins and outs of mitochondrial dysfunction in NASH
2004
Human anti-endoplasmic reticulum autoantibodies appearing in a drug-induced hepatitis are directed against a human liver cytochrome P-450 that hydroxylates the drug.
1987
Complementary/Alternative Medicine Use in a Comprehensive Cancer Center and the Implications for Oncology
2000 Standout
Two different dosages of cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis: Results of a prospective, randomized, multicenter study
1995
Prevention of aorta-coronary bypass graft occlusion. Beneficial effect of ticlopidine on early and late patency rates of venous coronary bypass grafts: a double-blind study.
1987
Traditional Remedies and Food Supplements
1997
Plant Products as Antimicrobial Agents
1999 Standout
Genetic Susceptibility to Toxic Epidermal Necrolysis
1987
Randomized trial comparing ceftriaxone with cefonicid for treatment of spontaneous bacterial peritonitis in cirrhotic patients
1993
Aortocoronary Saphenous Vein Graft Disease
1998 Standout
Alternative therapy use in neurologic diseases
1999
Multiple Myeloma
2011 Standout
Drug-induced liver disease
2000
HLA phenotypes and bullous cutaneous reactions to drugs
1986
Norfloxacin primary prophylaxis of bacterial infections in cirrhotic patients with ascites: a double-blind randomized trial
1998
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
Classification of chronic hepatitis: Diagnosis, grading and staging
1994 Standout
1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension
1999 Standout
Unsafe and potentially safe herbal therapies
1999
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins
2005 Standout
SPONTANEOUS BACTERIAL PERITONITIS
1992
Macrolide Antibacterials
1995
Hepatitis after the use of germander, a herbal remedy.
1996
Works of M Biour being referenced
Imatinib mesylate-induced acute hepatitis in a patient treated for gastrointestinal stromal tumour
2006
Metabolism and toxicity of coumarin on cultured human, rat, mouse and rabbit hepatocytes
1996
Liver and inflammatory bowel disease
2009
Amoxicillin–Clavulanic Acid Therapy of Spontaneous Bacterial Peritonitis: A Prospective Study of Twenty–Seven Cases in Cirrhotic Patients
1990
Hepatitis after Germander (Teucrium chamaedrys) Administration: Another Instance of Herbal Medicine Hepatotoxicity
1992
Hépatotoxicité des médicaments 14e mise à jour du fichier bibliographique des atteintes hépatiques et des médicaments responsables
2004
Secnidazole-Induced Acute Pancreatitis: A New Side-Effect for an Old Drug?
2016
Bortezomib-Induced Acute Pancreatitis
2016
Mesalazine (5-aminosalicylic acid) induced chronic hepatitis
1999
[Ticlopidine: blood and liver involvement?].
1982
[Criteria of imputation of acute hepatitis to a drug. Results of consensus meetings].
1987
Drugs that may injure the respiratory system
1997
Zoledronic Acid and Renal Toxicity: Data from French Adverse Effect Reporting Database
2005
ADVERSE DRUG REACTION MONITORING: DOING IT THE FRENCH WAY
1985
Mitochondrial and Metabolic Effects of Nucleoside Reverse Transcriptase Inhibitors (NRTIs) in Mice Receiving One of Five Single- and Three Dual-NRTI Treatments
2003
[Theophylline overdose and hepatic test abnormalities associated with josamycin administration].
1990
Drug–Induced Hepatitis Associated With Anticytoplasmic Organelle Autoantibodies
1985
[Cough provoked by angiotensin-converting enzyme inhibitors. Effect of non-steroidal anti-inflammatory agents].
1988
Fatal hepatitis after herbal tea
1992
[Drug-induced hepatotoxicity. The 13th updated edition of the bibliographic database of drug-related liver injuries and responsible drugs].
2000
[Hepatotoxicity of drugs. A data bank of hepatic involvement and responsible drugs].
1987